Back to Search
Start Over
A novel intragastric balloon for treatment of obesity and type 2 diabetes. A two-center pilot trial
- Publication Year :
- 2021
-
Abstract
- Background and aims: Obesity with type-2 diabetes is a global challenge. Lifestyle interventions have limited effect for most patients. Bariatric surgery is highly effective, but resource-demanding, invasive and associated with serious complications. Recently, a new intragastric balloon was introduced, not requiring endoscopy for placement or removal (Elipse™, Allurion Inc., Natick, MA). The balloon is swallowed in a capsule and filled with water once in the stomach. The balloon self-deflates after 4 months and is naturally excreted. The present trial investigated balloon feasibility, safety and efficacy in patients with obesity and type-2 diabetes. Patients and methods: We treated 19 patients, with type-2 diabetes and body mass index (BMI) of 30.0-39.9 kg/m2 at two Norwegian centers with the Elipse balloon. Patient follow-up during balloon treatment mimicked real-world clinical practice, including dietary plan and outpatient visits. The primary efficacy endpoints were total body weight loss (TBWL) and HbA1c at weeks 16 and 52. Results: All patients underwent balloon insertion uneventfully as out-patients. Mean TBWL and HbA1c reduction after 16 and 52 weeks of balloon insertion was 3.9% (95%CI 2.1-5.7) and 0.8% (95%CI 1.9-3.5); and 7 (95%CI 4-10), and 1 (95%CI -6 to 9) mmol/mol, respectively. Adverse events occurred in two patients (10.5%): one developed gastric outlet obstruction, managed by endoscopic balloon removal; the other excessive vomiting and dehydration, managed conservatively. Conclusions: This first Scandinavian real-world clinical trial with a new minimally invasive intragastric balloon system demonstrated good feasibility, but did not confirm expected efficacy for weight loss and diabetes control.
- Subjects :
- medicine.medical_specialty
Pilot Projects
Type 2 diabetes
Balloon
Body Mass Index
Weight loss
Diabetes mellitus
medicine
Humans
Obesity
Adverse effect
Gastric Balloon
business.industry
Gastroenterology
Gastric outlet obstruction
VDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710
medicine.disease
VDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710
Surgery
Obesity, Morbid
Clinical trial
Treatment Outcome
Diabetes Mellitus, Type 2
Vomiting
Feasibility Studies
medicine.symptom
business
Subjects
Details
- ISSN :
- 00365521
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....c3ec4d5076bfbe89679caf51a3f79e3a